Skip to content

Unani Polyherbal Approach for Chronic Tonsillitis.

To Evaluate The Clinical Efficacy Of Polyherbal Unani Formulation in The Management of Waram Al Lawzatayn Muzmin(Chronic Tonsillitis). - CT

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/08/093767
Enrollment
50
Registered
2025-08-27
Start date
Unknown
Completion date
Unknown
Last updated
2025-09-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J359- Chronic disease of tonsils and adenoids, unspecified

Interventions

Intervention1: Polyherbal Unani Formulation(Decoction): Patient will be given decoction(Joshanda) twice a day for 42 days. Control Intervention1: NIL: NIL

Sponsors

State Unani Medical College and HAHRDM Hospital Himmatganj Prayagraj
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients of either gender in the age group of 18-50 years. 2.Clinically diagnosed cases of Waram-e-Lawzatayn Muzmin (chronic tonsillitis) 3. Clinical Scoring System Severe- 9 or greater than 9. Moderate- 4-8 Mild- 3 or less than 3.

Exclusion criteria

Exclusion criteria: 1.Patients aged below 18 years and more than 50 years 2.Pregnant and lactating women 3.Patient with any complication of tonsillitis 4.Tonsillitis associated with any other systemic, metabolic, or chronic disease 5.Patient ?s unsure about attending schedule regularly.

Design outcomes

Primary

MeasureTime frame
Reduction in clinical scoring systemTimepoint: 7,14,21,28,35,and 42 days from baseline

Secondary

MeasureTime frame
Improvement in patient global assessment on Visual Analog Scale (VAS)Timepoint: 7,14,21,28,35 and 42 Days from baseline

Countries

India

Contacts

Public ContactKM Nasreen

State Unani Medical College Himmatganj Prayagraj Uttar Pradesh Pin Code 211016

arogyaherbal@gmail.com9415639877

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026